Table of Contents

company-logo

Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor proved for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It also has a pipeline of development programs to extend the marketed products into new indications and uses and bring new products using its proprietary formulation technology platforms, XeriSol and XeriJect. The company was incorporated in 2005 and is headquartered in Chicago, Illinois.

Xeris Biopharma Dividend Announcement

• Xeris Biopharma does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Xeris Biopharma dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Xeris Biopharma Dividend History

Xeris Biopharma Dividend Yield

Xeris Biopharma current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Xeris Biopharma stock? Use our calculator to estimate your expected dividend yield:

Xeris Biopharma Financial Ratios

P/E ratio-7.74
PEG ratio0.10
P/B ratio-17.25
ROE397.13%
Payout ratio0.00%
Current ratio1.79
Quick ratio1.29
Cash Ratio0.65

Xeris Biopharma Dividend FAQ

Does Xeris Biopharma stock pay dividends?
Xeris Biopharma does not currently pay dividends to its shareholders.
Has Xeris Biopharma ever paid a dividend?
No, Xeris Biopharma has no a history of paying dividends to its shareholders. Xeris Biopharma is not known for its dividend payments.
Why doesn't Xeris Biopharma pay dividends?
There are several potential reasons why Xeris Biopharma would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Xeris Biopharma ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Xeris Biopharma has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Xeris Biopharma a dividend aristocrat?
Xeris Biopharma is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Xeris Biopharma a dividend king?
Xeris Biopharma is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Xeris Biopharma a dividend stock?
No, Xeris Biopharma is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Xeris Biopharma stocks?
To buy Xeris Biopharma you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Xeris Biopharma stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.